APOE ε4 (ε4/ε4) homozygotes compared with persons homozygous for risk-neutral APOE ε3 (ε3/ε3) may have up to 15 times the increased the risk for developing Alzheimer disease while APOE ε4 heterozygotes (ε4/ε3 or ε4/ε2) only have a 4 times higher risk [25]. The gene discussed is APOE; the disease is Alzheimer disease.